rs73019664

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001365536.1(SCN9A):​c.3509T>C​(p.Ile1170Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000256 in 1,553,390 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 0.682

Publications

2 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008853674).
BP6
Variant 2-166242620-A-G is Benign according to our data. Variant chr2-166242620-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130263.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.3509T>C p.Ile1170Thr missense_variant Exon 19 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.3509T>C p.Ile1170Thr missense_variant Exon 19 of 27 NM_001365536.1 ENSP00000495601.1
SCN9AENST00000303354.11 linkc.3509T>C p.Ile1170Thr missense_variant Exon 19 of 27 5 ENSP00000304748.7
SCN9AENST00000409672.5 linkc.3476T>C p.Ile1159Thr missense_variant Exon 19 of 27 5 ENSP00000386306.1
SCN9AENST00000645907.1 linkc.3476T>C p.Ile1159Thr missense_variant Exon 19 of 27 ENSP00000495983.1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
186
AN:
152048
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00382
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000397
AC:
64
AN:
161404
AF XY:
0.000283
show subpopulations
Gnomad AFR exome
AF:
0.00386
Gnomad AMR exome
AF:
0.000241
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00135
Gnomad NFE exome
AF:
0.0000314
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000151
AC:
212
AN:
1401224
Hom.:
0
Cov.:
30
AF XY:
0.000133
AC XY:
92
AN XY:
691394
show subpopulations
African (AFR)
AF:
0.00372
AC:
118
AN:
31726
American (AMR)
AF:
0.000223
AC:
8
AN:
35874
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25154
East Asian (EAS)
AF:
0.0000278
AC:
1
AN:
36020
South Asian (SAS)
AF:
0.0000378
AC:
3
AN:
79278
European-Finnish (FIN)
AF:
0.00109
AC:
54
AN:
49580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000926
AC:
10
AN:
1079746
Other (OTH)
AF:
0.000310
AC:
18
AN:
58150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
152166
Hom.:
1
Cov.:
32
AF XY:
0.00122
AC XY:
91
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.00380
AC:
158
AN:
41536
American (AMR)
AF:
0.000262
AC:
4
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67986
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000524
Hom.:
0
Bravo
AF:
0.00120
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00287
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000295
AC:
32
Asia WGS
AF:
0.000289
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Jun 11, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 27, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 11, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:2
Mar 29, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 26, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN9A c.3476T>C (p.Ile1159Thr) results in a non-conservative amino acid change located in the Sodium ion transport-associated domain (IPR010526) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0004 in 161404 control chromosomes (gnomAD). c.3476T>C has been reported in the literature in an individual(s) affected with clinically-suspected neuropathy without strong evidence of causality (Antoniadi_2015). This report does not provide unequivocal conclusions about association of the variant with Primary Erythromelalgia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 26392352). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as likely benign (n=3) or uncertain significance (n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Inborn genetic diseases Benign:1
Jan 16, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

SCN9A-related disorder Benign:1
Mar 14, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
14
DANN
Benign
0.82
DEOGEN2
Benign
0.22
.;T;.;.;T;.
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.75
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.80
T;.;T;T;T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0089
T;T;T;T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.69
.;N;.;.;N;N
PhyloP100
0.68
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.7
N;.;.;.;.;N
REVEL
Benign
0.24
Sift
Benign
0.54
T;.;.;.;.;T
Sift4G
Benign
0.69
T;T;.;.;.;T
Vest4
0.081
MVP
0.33
MPC
0.15
ClinPred
0.0054
T
GERP RS
-0.48
Varity_R
0.14
gMVP
0.20
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73019664; hg19: chr2-167099130; API